» Articles » PMID: 26176405

Reflections on the Institute of Medicine's Systemic Exertion Intolerance Disease

Overview
Specialty General Medicine
Date 2015 Jul 16
PMID 26176405
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The Institute of Medicine (IOM) in the United States has recently proposed that the term systemic exertion intolerance disease (SEID) replace chronic fatigue syndrome. In addition, the IOM proposed a new case definition for SEID, which includes substantial reductions or impairments in the ability to engage in pre‑illness activities, unrefreshing sleep, postexertional malaise, and either cognitive impairment or orthostatic intolerance. Unfortunately, these recommendations for a name change were not vetted with patient and professional audiences, and the new criteria were not evaluated with data sets of patients and controls. A recent poll suggests that the majority of patients reject this new name. In addition, studies have found that prevalence rates will dramatically increase with the new criteria, particularly due to the ambiguity revolving around exclusionary illnesses. Findings suggest that the new criteria select more patients who have less impairment and fewer symptoms than several other criteria. The implications of these findings are discussed in the current review.

Citing Articles

Separating Patients with SEID from Those with CFS in the French ME/CFS Association, with Some Thoughts on Nomenclature.

Campagne J, Fornasieri I, Andreani B, Eginard M, de Korwin J Diagnostics (Basel). 2022; 12(5).

PMID: 35626248 PMC: 9139646. DOI: 10.3390/diagnostics12051095.


Cytokine network analysis in a community-based pediatric sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Jason L, Gaglio C, Furst J, Islam M, Sorenson M, Conroy K Chronic Illn. 2022; 19(3):571-580.

PMID: 35570777 PMC: 9666669. DOI: 10.1177/17423953221101606.


Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Following Infectious Mononucleosis.

Jason L, Cotler J, Islam M, Furst J, Katz B J Rehabil Ther. 2022; 4(1):1-5.

PMID: 35350440 PMC: 8959090. DOI: 10.29245/2767-5122/2021/1.1129.


Saliva Fatigue Biomarker Index As a Marker for Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in a Community Based Sample.

Jason L, Kalns J, Richarte A, Katz B, Torres C Fatigue. 2022; 9(4):189-195.

PMID: 35186443 PMC: 8855987. DOI: 10.1080/21641846.2021.1994222.


Clinical Profile and Aspects of Differential Diagnosis in Patients with ME/CFS from Latvia.

Krumina A, Vecvagare K, Svirskis S, Gravelsina S, Nora-Krukle Z, Gintere S Medicina (Kaunas). 2021; 57(9).

PMID: 34577881 PMC: 8467618. DOI: 10.3390/medicina57090958.


References
1.
Jason L, Taylor R, Plioplys S, Stepanek Z, Shlaes J . Evaluating attributions for an illness based upon the name: chronic fatigue syndrome, myalgic encephalopathy and Florence Nightingale disease. Am J Community Psychol. 2002; 30(1):133-48. DOI: 10.1023/A:1014328319297. View

2.
Jason L . Small wins matter in advocacy movements: giving voice to patients. Am J Community Psychol. 2011; 49(3-4):307-16. DOI: 10.1007/s10464-011-9457-7. View

3.
Reyes M, Gary Jr H, Dobbins J, Randall B, Steele L, Fukuda K . Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ. 1997; 46(2):1-13. View

4.
Jason L, Kot B, Sunnquist M, Brown A, Evans M, Jantke R . Chronic Fatigue Syndrome and Myalgic Encephalomyelitis: Toward An Empirical Case Definition. Health Psychol Behav Med. 2015; 3(1):82-93. PMC: 4443921. DOI: 10.1080/21642850.2015.1014489. View

5.
Holmes G, Kaplan J, Gantz N, Komaroff A, Schonberger L, Straus S . Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988; 108(3):387-9. DOI: 10.7326/0003-4819-108-3-387. View